DTC Fines May Be More Useful To Advertising Opponents Than An FDA Ban
Executive Summary
Opponents of direct-to-consumer television ads will be better off with FDA having authority to fine companies for false and misleading television ads than they would have been if the agency was given the power to simply ban such ads, according to Scott Lassman, former Senior Assistant General Counsel at Pharmaceutical Research and Manufacturers of America
You may also be interested in...
Advertising Regulation Wiki? Industry Wants Authoritative But Frequently Updated FDA Guidance (And/Or Regs) On Internet Drug Promotion
It's up to FDA now to outline a "how-to" for drug makers when it comes to using the Internet and social media for drug promotion - with guidance, regulations or both. But drug makers made evident in comments on the agency's meeting last fall that FDA also must determine how to account for changing technologies
Advertising Regulation Wiki? Industry Wants Authoritative But Frequently Updated FDA Guidance (And/Or Regs) On Internet Drug Promotion
It's up to FDA now to outline a "how-to" for drug makers when it comes to using the Internet and social media for drug promotion - with guidance, regulations or both. But drug makers made evident in comments on the agency's meeting last fall that FDA also must determine how to account for changing technologies
DTC User Fee Program’s Demise Leaves Advertisers Bobbing In Its Wake
FDA's formal termination of the user fee program for review of direct-to-consumer advertising does not resolve the regulatory uncertainty surrounding the ads. Sponsors are now faced with the prospect of stricter penalties for advertising violations without an expedited means of obtaining immunity from them